T/CHSA 004-2021 Active Group standards

T/CHSA 004-2021 Expert Consensus on Photodynamic Therapy for Oral Potential Malignant Diseases with 5-Aminolevulinic Acid

Publish Date: 2021-06-25 Implement Date: 2021-07-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CHSA 004-2021

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medical devices

ICS Name: Dental Comprehensive Care

Publish Date: 2021-06-25

Implement Date: 2021-07-01

Scope

Main technical content: Photodynamic therapy is an emerging and developing interdisciplinary field that integrates pharmacy, optics, chemistry, metrology, cell and molecular biology, therapeutics, and various clinical disciplines. It is a combined drug-device therapy that uses photosensitizers and light sources. Under the participation of oxygen molecules in biological tissues, photochemical reactions produce cytotoxic substances (such as singlet oxygen) to selectively destroy diseased tissues without causing damage to normal tissues. In recent years, oral mucosal disease researchers have also gradually applied photodynamic therapy to treat some oral mucosal diseases, achieving good results. This consensus addresses the clinical issues of treating potential malignant diseases in the oral cavity at the current stage and provides a scientific basis for treatment.